Eli Lilly and Company just announced new pricing for Zepbound (tirzepatide), signaling a strategic response to ongoing market pressures: Lowering the price of the 2.5 mg dose to $350 Lowering the price of the 5 mg dose to $499 per month Launching the Zepbound Self Pay Journey Program, which reduces the 7.5 mg ($599) and 10 mg ($699) doses to $499 per month at first fill and on refills within 45 days This move comes as GLP-1 manufacturers continue to face competitive pressure from dozens of compounding pharmacies offering GLP-1s at a fraction of the cost of branded products
Product LIPOSOMAL CALCIUM Liposomal calcium is an advanced calcium supplement utilizing liposomal encapsulation to enhance bioavailability and promote optimal absorption for bone health and muscle function
The paper suggests this drug contributes to an 11.85% reduction in body weight from baseline compared to placebo
Without systematic human studies, we simply dont know the true risk profile
Treatmentswhether topical, device-led, or surgicalwork by either stimulating new collagen, reorganising existing fibres, or removing excess tissue entirely
7 Compared to other antidiabetic drugs, GLP-1 RAs have the advantage of only being pharmacologically active when blood glucose levels are high